Baseline values from the electrocardiograms of children and adolescents with ADHD

Por Prasad, Suyash, Furr, Amanda J, Zhang, Shuyu, Ball, Susan, Allen, Albert J
Publicado em 2007

A Pharmaceutical Bioethics Consultation Service: Six-Year Descriptive Characteristics and Results of a Feedback Survey

Por Van Campen, Luann E., Allen, Albert J., Watson, Susan B., Therasse, Donald G.
Publicado no AJOB Empir Bioeth (2015)

A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorder

Por Carlson, Gabrielle A, Dunn, David, Kelsey, Douglas, Ruff, Dustin, Ball, Susan, Ahrbecker, Lisa, Allen, Albert J
Publicado em 2007

A Randomized Trial of Edivoxetine in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder

Por Lin, Daniel Y., Kratochvil, Christopher J., Xu, Wen, Jin, Ling, D'Souza, Deborah N., Kielbasa, William, Allen, Albert J.
Publicado em 2014

Baseline characteristics of European and non-European adult patients with attention deficit hyperactivity disorder participating in a placebo-controlled, randomized treatment study...

Por Upadhyaya, Himanshu, Adler, Lenard A, Casas, Miguel, Kutzelnigg, Alexandra, Williams, David, Tanaka, Yoko, Arsenault, Jody, Escobar, Rodrigo, Allen, Albert J
Publicado em 2013

Effects of atomoxetine on the QT interval in healthy CYP2D6 poor metabolizers

Por Loghin, Corina, Haber, Harry, Beasley, Charles M, Kothare, Prajakti A, Kauffman, Lynnette, April, John, Jin, Ling, Allen, Albert J, Mitchell, Malcolm I
Publicado em 2013

A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder

Por Upadhyaya, Himanshu P., Desaiah, Durisala, Schuh, Kory J., Bymaster, Frank P., Kallman, Mary J., Clarke, David O., Durell, Todd M., Trzepacz, Paula T., Calligaro, David O., Nisenbaum, Eric S., Emmerson, Paul J., Schuh, Leslie M., Bickel, Warren K., Allen, Albert J.
Publicado em 2013